Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineering and the challenges within.

Sara L Wargo1, Thangappan Ravi Kumar, Alan J Russell

  • 1McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Cell Transplantation
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy Volunteers.

Journal of clinical pharmacology·2026
Same author

Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label study.

EBioMedicine·2026
Same author

Exploring the evidence for the use of protein biomarkers of muscular damage and disease progression in Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis protocol.

BMJ open·2025
Same author

Short-term daily deflazacort decreases membrane permeability and increases maximum force in <i>mdx</i> mice.

American journal of physiology. Cell physiology·2025
Same author

Heterozygous <i>MYH7</i> R403Q mutation impairs left atrial mitochondrial function in a Yucatan mini-pig model of genetic nonobstructive hypertrophic cardiomyopathy.

Journal of applied physiology (Bethesda, Md. : 1985)·2025
Same author

A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy.

Muscle & nerve·2025
Same journal

Transplantation of human umbilical mesenchymal stromal cells attenuates heart failure progression in a rat model.

Cell transplantation·2026
Same journal

Three-dimensionally printed mesoporous bioactive glass for craniomaxillofacial bone regeneration: Material evolution, functional mechanisms, and clinical translation.

Cell transplantation·2026
Same journal

Hotspots and trends in stem cell therapy for ligament injuries: A bibliometric analysis (2001-2025).

Cell transplantation·2026
Same journal

Amniotic epithelial cells enhance islet engraftment by suppressing early inflammation in intraportal transplantation.

Cell transplantation·2026
Same journal

Cdc42-Modified BMSC-Derived exosomes promote acellular nerve allografts to bridge sciatic nerve defects.

Cell transplantation·2026
Same journal

Organ-on-a-chip as a next-generation tool in drug development: A bibliometric and patent analysis.

Cell transplantation·2026
See all related articles

Tissue engineering faces challenges in materials, cells, and integration. A novel biomaterial scaffold seamlessly bridges synthetic and biologic systems for improved tissue regeneration.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Regenerative Medicine

Background:

  • Tissue engineering aims to restore, maintain, or improve tissue function.
  • Significant hurdles exist in material design, cell sourcing, in vitro culturing, and in vivo integration.
  • Current biomaterials often struggle to effectively interface with biological systems.

Purpose of the Study:

  • To address the challenges in tissue engineering by proposing a novel biomaterial design.
  • To develop a scaffold that acts as a seamless bridge between synthetic and biologic materials.
  • To facilitate the integration of engineered tissues into the body.

Main Methods:

  • Exploration of challenges in material design for tissue engineering.
  • Investigation into therapeutic cell source selection and in vitro culturing techniques.

Related Experiment Videos

  • Development and testing of a novel scaffold designed to interface biotic and abiotic components.

    • Main Results:

    • Identification of key scientific and societal challenges in tissue engineering.
    • Successful design of a transitional biomaterial scaffold.
    • Demonstration of the scaffold's ability to bridge synthetic and biologic materials.

    Conclusions:

    • The developed scaffold offers a promising solution for integrating engineered tissues.
    • This approach facilitates a seamless transition between synthetic materials and biological systems.
    • Overcoming integration challenges is crucial for advancing tissue engineering applications.